Sorafenib tosylate novel drug delivery systems: Implications of nanotechnology in both approved and unapproved indications-Reference-Cited by-同舟云学术

Sorafenib tosylate novel drug delivery systems: Implications of nanotechnology in both approved and unapproved indications

Published:2022-11 Issue: Volume:8 Page:100103
ISSN:2352-9520
Container-title:OpenNano
language:en
Short-container-title:OpenNano

Author:

Raut Hrushikesh,Jadhav Chetana,Shetty Karishma,Laxane Neha,Nijhawan Harsh P.,Rao GSN Koteswara,Alavala Rajasekhar Reddy,Joshi Garima,Patro Ch. Niranjan,Soni Govind,Yadav Khushwant S.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Biotechnology,Internal Medicine

Reference92 articles.

1. Polymers, responsiveness and cancer therapy;Pethe;Artif. Cells Nanomed. Biotechnol.,2019

2. Antineoplastic Agents;Eldridge;Compr. Toxicol. Third Ed.,2021

3. Understanding the biology and advent of physics of cancer with perspicacity in current treatment therapy;Korgaonkar;Life sciences,2019

4. Tyrosine kinase inhibitors in cancer: breakthrough and challenges of targeted therapy;Pottier;Cancers,2020

5. Targeting RAS signalling pathways in cancer therapy;Downward;Nat. Rev. Cancer,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and evaluation of biodegradable alginate beads loaded with sorafenib for cancer treatment;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-12

2. Understanding the journey of biopolymeric nanoformulations for oral drug delivery: Conventional to advanced treatment approaches;European Polymer Journal;2024-09

3. Inulin Amphiphilic Copolymer-Based Drug Delivery: Unraveling the Structural Features of Graft Constructs;Pharmaceutics;2024-07-23

4. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles;Therapeutic Delivery;2024-05-09

5. Natural Polymer-Based Nanogel for pH-Responsive Delivery of Sorafenib Tosylate in Hemangiosarcoma;AAPS PharmSciTech;2024-04-11